Search
for

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 97 results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  135 upvotes 1 year ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community 10 month update - 1 mg oral fin

      in Is this regrowth?  52 upvotes 1 month ago
      The user reports significant hair regrowth after 10 months using 1 mg oral finasteride daily and a 1.25 mm derma stamp bi-weekly with rosemary and jojoba oil. Other users commend the progress and inquire about the routine and side effects.

      community 3 Months of 2.5 minoxidil + 1mg finasteride

      in Progress Pictures  38 upvotes 9 months ago
      User reports hair improvement after 3 months using 2.5% minoxidil, 1mg finasteride, weekly Nizoral, bi-weekly microneedling, and nightly rosemary oil. Shedding has decreased, and no significant side effects were noted.

      community Progress photo shy of 1.5 years

      in Progress Pictures  14 upvotes 1 year ago
      User shared a progress photo after 1.5 years of using 1mg Finasteride daily, 5% Minoxidil twice daily, Nizoral shampoo and conditioner 2-3 times weekly, and derma stamping bi-weekly. The post is categorized under "Progress Pictures."

      community Slow going. Min/Fin topical, 1.5 microneedling

      in Progress Pictures  46 upvotes 1 year ago
      The user shared progress pictures after a year of treating hair loss with 5% minoxidil, then a combination of minoxidil/finasteride topical, and microneedling at 1.5mm bi-weekly. They plan to switch to oral finasteride and more frequent microneedling at a shallower depth while continuing the current regimen.